COVID-19
Diagnostics & testing

FIND and The Global Fund are co-conveners of the Access to COVID-19 Tools (ACT) Accelerator Diagnostics Pillar. The ACT-Accelerator is a ground-breaking global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines. It was set up in response to a call from G20 leaders in March and launched by the WHO, the European Commission, France and the Bill & Melinda Gates Foundation in April 2020.

This diagnostics resource centre provides information, updates and progress on tests and testing, in support of the agenda set out in the ACT-Accelerator Diagnostics Pillar investment case.

Call to action: global crisis on testing

Testing is vital to save lives today, to develop and deploy vaccines and effective treatments without delay, to protect healthcare workers and strengthen health systems against future threats, to inform the safe reopening of economies, and to protect the global health gains of recent decades.

The window of opportunity to invest in and ramp up testing is closing. Missing this opportunity may lead to delays in vaccine and treatment roll out, excessive spending on healthcare, and greater economic losses due to unnecessary lockdowns.

JOIN the call to action

Expressions of interest: antigen RDTs

Call for expressions of interest (EOI) now open to accelerate the availability and manufacturing scale-up of rapid diagnostic tests for the detection of SARS-CoV-2 antigens.

Innovators, RDT developers, IVD manufacturers and LMIC-based diagnostic stakeholders are invited to apply. A range of funding mechanisms could be applied according to the needs of each business case.

More information & APPLICATIONS

SARS-CoV-2 DIAGNOSTIC
PIPELINE

We are continually updating our searchable database showing the current status of SARS-CoV-2 tests in development and commercialized.

SARS-COV-2
DIAGNOSTIC PIPELINE

Independent test evaluations

We are conducting independent evaluations of molecular tests and immunoassays, in collaboration with WHO and multiple partners worldwide, to assist in-country decision making.

FIND evaluations of SARS-COV-2 ASSAYs

SARS-CoV-2 DIAGNOSTIC
PERFORMANCE DATA

We are collating and centralizing performance data on commercially available in vitro diagnostic tests for SARS-CoV-2 as a global public good.

SARS-COV-2 DIAGNOSTIC PERFORMANCE DATA

Using rapid diagnostic tests for COVID-19

Understand more about rapid diagnostic tests for COVID-19 – how they work, benefits of using different tests in different scenarios, and interpretation of results.

RAPID DIAGNOSTIC TESTS FOR COVID-19

Current testing situation worldwide

Our interactive map tracks the number of SARS-CoV-2 tests reported to have been performed in each country, and compares it with the number that showed a positive result, to build a picture of how many people in the world are being tested for COVID-19.

INTERACTIVE SARS-CoV-2 TEST-TRACKER

Diagnostics implementation simulator

Discover our Diagnostic Implementation Simulator for SARS-CoV-2 diagnostics, developed in partnership with the EPFL Blue Brain Project and Ateneo de Manila University. It uses modeling data to simulate scenarios and estimate the potential impact of deploying different testing strategies for COVID-19.

DX Implementation simulator

Online training
COVID-19 diagnostics and testing

Join over 16,000 learners from 186 countries and sign up for the free online training course we have developed in partnership with ASLM and LSHTM, hosted by FutureLearn. The second run of the 3-week course launched on 15 June 2020 and will be available for 5 weeks. The French version of the online training launched on 20 July 2020 and has been developed in partnership with Fondation Mérieux. These courses can be followed at your own pace and is designed for Ministry of Health officials, laboratory professionals, clinicians and anyone involved in laboratory testing and diagnosis for COVID-19, with a focus on low- and-middle-income settings.

enrol in english course

enrol in french course

ENROL IN LAB COURSE

Media & Press

Time to tap Covid-19 innovations & systems to reimagine TB care
Read more
Covid-19 tests that give results in minutes to be rolled out across world
Read more
Rapid, affordable, high quality COVID tests still scant
Read more
The breakthrough that could halt the pandemic, even before a vaccine
Read more
Diagnosis of neglected tropical diseases during and after the COVID-19 pandemic
Read more
Decentralized HCV testing is key to finding the missing millions
Read more
Rapid COVID-19 testing breaks free from the lab
Read more
Saving lives from COVID-19 is everyone’s responsibility
Read more
Where is the money for COVID-19 diagnostics?
Read more
‘The biggest monster’ is spreading. And it’s not the coronavirus.
Read more
Jeremy Hunt's clash with Whitty puts testing regime under the spotlight
Read more
Opinion: To enable UHC, close COVID-19 testing and gender gaps
Read more
How to cap the virus in the current situation: cast the testing net wider and act fast on the data
Read more
Three questions (Catharina Boehme)
Read more
WHO seeks $6B diagnostics support for unrelenting COVID-19 pandemic
Read more
Dr Tom Frieden: 'Blaming CDC for US Covid failures is like blaming someone encased in concrete for failing to swim'
Read more
Care in the time of COVID-19
Read more
'Global Goal: Unite for Our Future,’ Global Citizen and the European Commission mobilize $1.5 billion in cash grants, and $5.4 billion in loans and guarantees—for a total of $6.9 billion pledged—to combat the disproportionate impact of Covid-19 on vulnerable and disadvantaged communities
Read more
Developing countries face diagnostic challenges as the COVID-19 pandemic surges
Read more
Antibody tests for identification of current and past infection with SARS‐CoV‐2
Read more
Women leaders unite to push for testing to exit COVID-19
Read more
UK R&D funding goes global
Read more
How Reliable Are COVID-19 Tests?
Read more
Who are the key players in making COVID-19 tests, treatments, and vaccines available to everyone?
Read more
Testing funds shortfall imperils Covid-19 fight, health groups warn
Read more
India needs to ensure that testing is at the heart of its response to Covid-19
Read more
Beset by COVID-19 pandemic, Europe searches for right test mix for diagnosis, surveillance
Read more
Is there still a case for testing contacts?
Read more
'Global goal: unite for our future': we're calling on the world to make sure everyone can beat COVID-19
Read more
La grande foire aux tests sérologiques
Read more
Global TB community must unite – 1.4 million lives are at stake
Read more
Dockyard : All about COVID-19 tests
Read more
How COVID-19 testing works
Read more
What African nations are teaching the West about fighting the coronavirus
Read more
Why the accuracy of SARS-CoV-2 antibody tests vary so much
Read more
First batch of Covid-19 test kits funded by Pepsico arrive at sites across India
Read more
PepsiCo India-funded COVID-19 testing kits start reaching laboratories
Read more
Demand for coronavirus tests raises concerns over HIV and malaria
Read more
Testing times – Letters to the Editor
Read more
Senegal working on $1 testing kit for Covid-19, say reports as number of cases in Africa cross 22,000
Read more
We must never forget TB is still out there
Read more
Q&A on COVID-19 antibody tests
Read more
Mologic launches manufacturing facility to boost access to COVID-19 rapid diagnostic tests
Read more
Diagnosis of SARS‐CoV‐2 infection and COVID‐19: accuracy of signs and symptoms; molecular, antigen, and antibody tests; and routine laboratory markers
Read more
Diagnosing malaria and other febrile illnesses during the COVID-19 pandemic
Read more
UK ‘key’ funder of Covid-19 tests in developing nations
Read more
Ramping up diagnostics in resource-poor countries
Read more
Testing the tests: Which COVID-19 tests are most accurate?
Read more
Diagnostic testing for severe acute respiratory syndrome–related Coronavirus-2: A narrative review
Read more
COVID-19 and risks to the supply and quality of tests, drugs, and vaccines
Read more
In scramble for coronavirus supplies, rich countries push poor aside
Read more
South Korea’s factories stretched to limit churning out virus test
Read more
This is no time for ‘America First.’ China’s coronavirus tests are good enough for the U.S.
Read more
PepsiCo India commits over 5 million meals and 25,000 COVID-19 testing kits
Read more
GlobalData: Rapid POC tests to accelerate testing capacity for diagnosing COVID-19
Read more
How do coronavirus tests work?
Read more
What coronavirus tests does the world need to track the pandemic? | Free to read
Read more
'Absolutely wrong': how UK's coronavirus test strategy unravelled
Read more
New testing kits could turn tide against coronavirus-if they work
Read more
Just 2,000 key NHS staff have been tested, UK government admits
Read more
Esto es lo que sabemos de las pruebas rápidas para detectar COVID-19
Read more
A look at COVID-19 testing and why country-wide is impossible right now
Read more
New Tests Could Turn Tide Against Coronavirus—If They Work
Read more
25,000 tests a day in UK ‘not going to be adequate’ – FIND’s Dr Rangarajan Sampath
Read more
Why the U.S. coronavirus testing failures were inevitable
Read more
Catharina Boehme: «Il y a une crise évidente dans la disponibilité des tests du coronavirus»
Read more
AIDS, TB and malaria: Coronavirus threatens the endgame
Read more
Many will say globalisation got us into this mess. In reality, it is what will get us out of it
Read more
UK Government invests $28M in FIND to support SARS-CoV-2 test development
Read more
Trump’s faulty testing claims
Read more
U.K. trials coronavirus-immunity tests for home use
Read more
Q&A: FIND's Cassandra Kelly-Cirino discusses COVID-19 diagnostics pipelines
Read more
Des tests sérologiques déployés sous peu pour voir l'étendue réelle du Covid-19 en Suisse
Read more
Fast, portable tests come online to curb coronavirus pandemic
Read more
Biden, Trump wrong about WHO coronavirus tests
Read more
COVID-19 coronavirus and tuberculosis: We need a damage control plan
Read more
Let’s worry about diagnostic capacity, not just during outbreaks
Read more
On stigma and outbreak response
Read more